{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:17:54Z","timestamp":1792700274699,"version":"4.5.0"},"reference-count":38,"publisher":"Begell House","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Eukaryot Gene Expr"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>&lt;b&gt;Background: &lt;\/b&gt;The HECT, C2, and WW domain-containing E3 ubiquitin protein ligase 1 (HECW1) gene is a member of the HECT family of E3 ubiquitin ligases. While HECW1 has been implicated in various cancers, its role in gastric cancer (GC) remains unclear.\n\n&lt;b&gt;Methods:&lt;\/b&gt; Bioinformatics approaches were employed to investigate HECW1's role in GC. Functional assays, including the CCK-8, transwell migration, and wound healing assays, were performed to assess its impact on GC cell proliferation, invasion, and migration.\n\n&lt;b&gt;Results: &lt;\/b&gt;HECW1 expression was significantly upregulated in GC tissues compared to normal controls, correlating with specific clinical characteristics. Cox regression analyses identified HECW1 as an independent prognostic factor for GC. Prognostic nomograms accurately predicted 1-, 3-, and 5-year survival rates, with calibration curves closely aligned with the ideal diagonal line. Elevated HECW1 expression was associated with poorer overall survival and disease progression outcomes. ROC analyses demonstrated that HECW1 had strong predictive power for outcomes (AUC &amp;#61; 0.746, CI &amp;#61; 0.683-0.808) and five-year survival rates (AUC &amp;#61; 0.734, CI &amp;#61; 0.600-0.869). Enrichment analysis suggested HECW1's involvement in protein processing and interactions with substrates such as SMAD4, TTF1, DVL1, and NEDD4. Functional assays showed that HECW1 knockdown significantly reduced GC cell proliferation, invasion, and migration.\n\n&lt;b&gt;Conclusions:&lt;\/b&gt; HECW1 acts as an oncogene in GC and represents a potential prognostic indicator. Targeting HECW1 may inhibit GC progression, providing a promising therapeutic strategy.\n\n<\/p>","DOI":"10.1615\/critreveukaryotgeneexpr.2025058112","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T15:15:31Z","timestamp":1741014931000},"page":"1-16","source":"Crossref","is-referenced-by-count":2,"title":["HECW1 Gene's Role in Gastric Cancer Prognosis and Its Suppressive Effect on Cell Progression after Knockdown"],"prefix":"10.1615","volume":"35","author":[{"given":"Jinchuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: Recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57.","DOI":"10.1186\/s13045-023-01451-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Chen M, Chen K, Hou H, Li W, Wang X, Dao Q, Wang Z. Incidence and mortality trends in gastric cancer in the United States, 1992-2019. Int J Cancer. 2023;152(9):1827-36.","DOI":"10.1002\/ijc.34415"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Liu KS, Raza SA, El-Serag HB, Thrift AP. Recent trends in the incidence of gastric cancer in the United States. J Clin Gastroenterol. 2024;58(1):39-45.","DOI":"10.1097\/MCG.0000000000001811"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, Farjah F, Gerdes H, Gibson MK, Hochwald S, Hofstetter WL, Ilson DH, Keswani RN, Kim S, Kleinberg LR, Klempner SJ, Lacy J, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Outlaw D, Park H, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian N, Pluchino LA. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2022;20(2):167-92.","DOI":"10.6004\/jnccn.2022.0008"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264-79.","DOI":"10.3322\/caac.21657"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39(7):1010428317714626.","DOI":"10.1177\/1010428317714626"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Hou W, Kong L, Hou Z, Ji H. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer. BMC Med Genom. 2022;15(1):225.","DOI":"10.1186\/s12920-022-01383-w"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Matsuoka T, Yashiro M. Novel biomarkers for early detection of gastric cancer. World J Gastroenterol. 2023;29(17):2515-33.","DOI":"10.3748\/wjg.v29.i17.2515"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Lu XQ, Zhang JQ, Zhang SX, Qiao J, Qiu MT, Liu XR, Chen XX, Gao C, Zhang HH. Identification of novel hub genes associated with gastric cancer using integrated bioinformatics analysis. BMC Cancer. 2021;21(1):697.","DOI":"10.1186\/s12885-021-08358-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Wilkinson KD. Ubiquitination and deubiquitination: Targeting of proteins for degradation by the proteasome. Semin Cell Dev Biol. 2000;11(3):141-8.","DOI":"10.1006\/scdb.2000.0164"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Wang D, Ma L, Wang B, Liu J, Wei W. E3 ubiquitin ligases in cancer and implications for therapies. Cancer Metastasis Rev. 2017;36(4):683-702.","DOI":"10.1007\/s10555-017-9703-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Chen C, Matesic LE. The Nedd4-like family of E3 ubiquitin ligases and cancer. Cancer Metastasis Rev. 2007;26(3-4):587-604.","DOI":"10.1007\/s10555-007-9091-x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Miyazaki K, Fujita T, Ozaki T, Kato C, Kurose Y, Sakamoto M, Kato S, Goto T, Itoyama Y, Aoki M, Nakagawara A. NEDL1, a novel ubiquitin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1. J Biol Chem. 2004;279(12):11327-35.","DOI":"10.1074\/jbc.M312389200"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Wang C, Dong K, Wang Y, Peng G, Song X, Yu Y, Shen P, Cui X. Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma. BMC Cancer. 2021;21(1):890.","DOI":"10.1186\/s12885-021-08631-9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Lin Y, Gong H, Liu J, Hu Z, Gao M, Yu W, Liu J. HECW1 induces NCOA4-regulated ferroptosis in glioma through the ubiquitination and degradation of ZNF350. Cell Death Dis. 2023;14(12):794.","DOI":"10.1038\/s41419-023-06322-w"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Xu Z, Guo Y, Wang L, Cui J. HECW1 restrains cervical cancer cell growth by promoting DVL1 ubiquitination and downregulating the activation of Wnt\/beta-catenin signaling. Exp Cell Res. 2024;435(2):113949.","DOI":"10.1016\/j.yexcr.2024.113949"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Lu C, Ning G, Si P, Zhang C, Liu W, Ge W, Cui K, Zhang R, Ge S. E3 ubiquitin ligase HECW1 promotes the metastasis of non-small cell lung cancer cells through mediating the ubiquitination of Smad4. Biochem Cell Biol. 2021;99(5):675-81.","DOI":"10.1139\/bcb-2020-0505"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108-e10.","DOI":"10.1158\/0008-5472.CAN-17-0307"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Blum A, Wang P, Zenklusen JC. SnapShot: TCGA-analyzed tumors. Cell. 2018;173(2):530.","DOI":"10.1016\/j.cell.2018.03.059"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson \u00c3\u0085, Kampf C, Sjostedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Ponten F. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.","DOI":"10.1126\/science.1260419"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne U, Creighton CJ, Varambally S. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18-27.","DOI":"10.1016\/j.neo.2022.01.001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Xu Y, Zhang M, Shi Q, Cheng X, Du R, Li C, Zhang Y. Identification of HOXB9 to predict prognosis of endometrial cancer based on comprehensive bioinformatics analysis. Eur J Med Res. 2023;28(1):79.","DOI":"10.1186\/s40001-022-00979-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: More than meets the eye. Lancet Oncol. 2015;16(4):e173-80.","DOI":"10.1016\/S1470-2045(14)71116-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Wang H, Zhang J, Li H, Yu H, Chen S, Liu S, Zhang C, He Y. FN1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers. Front Oncol. 2022;12:918719.","DOI":"10.3389\/fonc.2022.918719"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556-w60.","DOI":"10.1093\/nar\/gkz430"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Wang X, Li Y, He M, Kong X, Jiang P, Liu X, Diao L, Zhang X, Li H, Ling X, Xia S, Liu Z, Liu Y, Cui CP, Wang Y, Tang L, Zhang L, He F, Li D. UbiBrowser 2.0: A comprehensive resource for proteome-wide known and predicted ubiquitin ligase\/deubiquitinase-substrate interactions in eukaryotic species. Nucleic Acids Res. 2022;50(D1):D719-d28.","DOI":"10.1093\/nar\/gkab962"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635-48.","DOI":"10.1016\/S0140-6736(20)31288-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY, Pu J, Lv J. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol. 2023;29(16):2452-68.","DOI":"10.3748\/wjg.v29.i16.2452"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: Epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023;20(5):338-49.","DOI":"10.1038\/s41571-023-00747-0"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Li X, Xu J, Xie J, Yang W. Research progress in targeted therapy and immunotherapy for gastric cancer. Chin Med J. 2022;135(11):1299-313.","DOI":"10.1097\/CM9.0000000000002185"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Swatek KN, Komander D. Ubiquitin modifications. Cell Res. 2016;26(4):399-422.","DOI":"10.1038\/cr.2016.39"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 2020;19(1):146.","DOI":"10.1186\/s12943-020-01262-x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Sun Y. Targeting E3 ubiquitin ligases for cancer therapy. Cancer Biol Ther. 2003;2(6):623-9.","DOI":"10.4161\/cbt.2.6.677"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Sampson C, Wang Q, Otkur W, Zhao H, Lu Y, Liu X, Piao HL. The roles of E3 ubiquitin ligases in cancer progression and targeted therapy. Clin Transl Med. 2023;13(3):e1204.","DOI":"10.1002\/ctm2.1204"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 1996;271(5247):350-3.","DOI":"10.1126\/science.271.5247.350"},{"key":"37","unstructured":"Xiangming C, Natsugoe S, Takao S, Hokita S, Ishigami S, Tanabe G, Baba M, Kuroshima K, Aikou T. Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer. Clin Cancer Res. 2001;7(2):277-82."},{"key":"38","doi-asserted-by":"crossref","unstructured":"Lee JH, Kim SS, Lee HS, Hong S, Rajasekaran N, Wang LH, Choi JS, Shin YK. Upregulation of SMAD4 by MZF1 inhibits migration of human gastric cancer cells. Int J Oncol. 2017;50(1):272-82.","DOI":"10.3892\/ijo.2016.3793"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144(5):646-74.","DOI":"10.1016\/j.cell.2011.02.013"}],"container-title":["Critical Reviews in Eukaryotic Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/087f09577477f749\/CRE(1)-58112 Li.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:37:57Z","timestamp":1750743477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/6dbf508d3b17c437,3f752e004be8e7df,087f09577477f749.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critreveukaryotgeneexpr.2025058112","relation":{},"ISSN":["1045-4403"],"issn-type":[{"value":"1045-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}